ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
NLS Pharmaceutics Ltd. Warrant
0.0179
0.0000
成交量：
- -
成交額：
- -
市值：
6.51萬
市盈率：
-0.01
高：
0.0179
開：
0.0179
低：
0.0179
收：
0.0179
52周最高：
0.0400
52周最低：
0.0009
股本：
363.64萬
流通股本：
363.64萬
量比：
1.51
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-2.0387
淨資產收益率：
-862.92%
總資產收益率：
-75.98%
市淨率：
0.02
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
2025/10/31
交易所摘牌聲明
Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend]
2023/05/05
年度報告
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/24
超過5%披露
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14
超過5%披露
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/02/14
超過5%披露
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/02/13
超過5%披露
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/01/18
SEC問詢函
Form CORRESP - Correspondence
2023/01/03
超過5%披露
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2022/12/16
超過5%披露
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/13
SEC問詢函
Form CORRESP - Correspondence
2021/05/14
年度報告
20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/17
超過5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04
超過5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/25
SEC問詢函
CORRESP [Cover] - Correspondence
2021/01/25
SEC問詢函
CORRESP [Cover] - Correspondence
2021/01/20
[修訂]招股説明書
F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/11/19
SEC問詢函
CORRESP [Cover] - Correspondence
2020/11/17
[修訂]招股説明書
F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/11/13
[修訂]招股説明書
F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/10/19
[修訂]招股説明書
F-1/A [Amend] - Registration statement for certain foreign private issuers
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NLSPW/filings"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NLSPW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLSPW\",,,,,undefined,":{"symbol":"NLSPW","market":"US","secType":"STK","nameCN":"NLS Pharmaceutics Ltd. Warrant","latestPrice":0.0179,"timestamp":1774036800000,"preClose":0.0179,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":3636363,"shares":3636363,"eps":-2.0387,"marketStatus":"停牌","change":0,"latestTime":"03-20 16:00:00 EDT","open":0.0179,"high":0.0179,"low":0.0179,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.0387,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":0.0179,"volumeRatio":1.5125016565401561},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLSPW\",,,,,undefined,":{"symbol":"NLSPW","floatShares":3636363,"roa":"-75.98%","roe":"-862.92%","lyrEps":0,"volumeRatio":1.5125016565401561,"shares":3636363,"dividePrice":0,"high":0.0179,"amplitude":0,"preClose":0.0179,"low":0.0179,"week52Low":0.0009,"pbRate":"0.02","week52High":0.04,"institutionHeld":0,"latestPrice":0.0179,"eps":-2.0387,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.0387,"open":0.0179,"prevYearClose":0.0179,"prevWeekClose":0.0179,"prevMonthClose":0.0179,"prevQuarterClose":0.0179,"fiveDayClose":0.0179,"twentyDayClose":0.0179,"sixtyDayClose":0.0179},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NLSPW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NLSPW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NLSPW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"NLSPW\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"20352837","market":"us","labels":[],"media":"sec.gov","original_id":"AN135445725001077-NLSPW","pdf_url":"","pub_time":1761857774000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend]","symbol":"NLSPW","title":"Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend]","titleType":"交易所摘牌聲明","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/0001354457-25-001077-index.html","us_notice_code":"Form 25-NSE/A","us_title_en":"Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1354457/000135445725001077/xslF25X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"25-NSE/A","id":"NTFILE9TZjgxxbgkkkEUmt","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Delisting","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"交易所摘牌聲明","pubTime":"2025-10-31 04:56","pubTimestamp":1761857774,"title_zh":"Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"16953163","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023036920-NLSPW","pdf_url":"","pub_time":1683259200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"NLSPW","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/0001213900-23-036920-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022_nlspharma.htm","primary":true,"translateUrl":"","linkName":"f20f2022_nlspharma.htm","type":"20-F","id":"NTFILE8ebiRVZEPFwCDX4z","market":"us","size":1718245},{"description":"DESCRIPTION OF SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022ex2-1_nlspharma.htm","primary":false,"translateUrl":"","linkName":"f20f2022ex2-1_nlspharma.htm","type":"EX-2.1","id":"NTFILEotDQYg48Crk1QZjd","market":"us","size":111376},{"description":"AMENDMENT NO. 1 TO PRE-FUNDED WARRANT DATED APRIL [__], 2023 BETWEEN NLS PHARMAC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022ex4-17_nlspharma.htm","primary":false,"translateUrl":"","linkName":"f20f2022ex4-17_nlspharma.htm","type":"EX-4.17","id":"NTFILEDQeWRq9e3YSPA65d","market":"us","size":25609},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022ex12-1_nlspharma.htm","primary":false,"translateUrl":"","linkName":"f20f2022ex12-1_nlspharma.htm","type":"EX-12.1","id":"NTFILE4SK4wCZHSgj4qPAs","market":"us","size":9729},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022ex12-2_nlspharma.htm","primary":false,"translateUrl":"","linkName":"f20f2022ex12-2_nlspharma.htm","type":"EX-12.2","id":"NTFILE8s2aNEY2rZDJimUg","market":"us","size":9703},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022ex13-1_nlspharma.htm","primary":false,"translateUrl":"","linkName":"f20f2022ex13-1_nlspharma.htm","type":"EX-13.1","id":"NTFILE4sBj4nDm3RtxS6ya","market":"us","size":3640},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022ex13-2_nlspharma.htm","primary":false,"translateUrl":"","linkName":"f20f2022ex13-2_nlspharma.htm","type":"EX-13.2","id":"NTFILEhZVFUBmKdEz6251H","market":"us","size":3485},{"description":"CONSENT OF PRICEWATERHOUSECOOPERS AG","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022ex15-1_nlspharma.htm","primary":false,"translateUrl":"","linkName":"f20f2022ex15-1_nlspharma.htm","type":"EX-15.1","id":"NTFILE3v4pbSUv3Yp4rDDy","market":"us","size":5288},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE57TkSCDwjEjPRBrY","market":"us","size":23053},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE9DkHyaPatAJTyQyV","market":"us","size":24993},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_003.jpg","primary":false,"translateUrl":"","linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILE6c5Sf3oSSSHUu9AW","market":"us","size":10760},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_004.jpg","primary":false,"translateUrl":"","linkName":"image_004.jpg","type":"GRAPHIC","id":"NTFILE3gfGm3E7sftfMWoe","market":"us","size":10771},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_005.jpg","primary":false,"translateUrl":"","linkName":"image_005.jpg","type":"GRAPHIC","id":"NTFILE9Q9amnuE9xWPwJaW","market":"us","size":7011},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_006.jpg","primary":false,"translateUrl":"","linkName":"image_006.jpg","type":"GRAPHIC","id":"NTFILECq4Fwqn9N7sqc8UC","market":"us","size":18434},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_007.jpg","primary":false,"translateUrl":"","linkName":"image_007.jpg","type":"GRAPHIC","id":"NTFILEHMowJ5wUCCEn84Qq","market":"us","size":15388},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_008.jpg","primary":false,"translateUrl":"","linkName":"image_008.jpg","type":"GRAPHIC","id":"NTFILE6KazBdVNCymmFZbJ","market":"us","size":17602},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_009.jpg","primary":false,"translateUrl":"","linkName":"image_009.jpg","type":"GRAPHIC","id":"NTFILE6ozcgTA7XtBF6EPM","market":"us","size":24015},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_010.jpg","primary":false,"translateUrl":"","linkName":"image_010.jpg","type":"GRAPHIC","id":"NTFILEGJPoat4tPq8fgD1T","market":"us","size":30348},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_011.jpg","primary":false,"translateUrl":"","linkName":"image_011.jpg","type":"GRAPHIC","id":"NTFILEB2vK1iPzHCAN485n","market":"us","size":13115},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_012.jpg","primary":false,"translateUrl":"","linkName":"image_012.jpg","type":"GRAPHIC","id":"NTFILE2s77AiArb1XeyGBb","market":"us","size":22595},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_013.jpg","primary":false,"translateUrl":"","linkName":"image_013.jpg","type":"GRAPHIC","id":"NTFILE7skQ9i77DNZDBjhA","market":"us","size":11242},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_014.jpg","primary":false,"translateUrl":"","linkName":"image_014.jpg","type":"GRAPHIC","id":"NTFILE4jP5TkUvo2K7hesH","market":"us","size":18456},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_015.jpg","primary":false,"translateUrl":"","linkName":"image_015.jpg","type":"GRAPHIC","id":"NTFILE6RcEPDPdfooXXCzu","market":"us","size":13760},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_016.jpg","primary":false,"translateUrl":"","linkName":"image_016.jpg","type":"GRAPHIC","id":"NTFILEGYpMoL4Mc38P2qjp","market":"us","size":18611},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_017.jpg","primary":false,"translateUrl":"","linkName":"image_017.jpg","type":"GRAPHIC","id":"NTFILEDx4MFhLviGRRQTGY","market":"us","size":36321},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/image_018.jpg","primary":false,"translateUrl":"","linkName":"image_018.jpg","type":"GRAPHIC","id":"NTFILEC8mgz63rUF66nLPo","market":"us","size":18610}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"年度報告","pubTime":"2023-05-05 12:00","pubTimestamp":1683259200,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17138252","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023014126-NLSPW","pdf_url":"","pub_time":1677214800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"NLSPW","title":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023014126/0001213900-23-014126-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023014126/ea174177-13ggrisard_nlsphar.htm","primary":true,"translateUrl":"","linkName":"ea174177-13ggrisard_nlsphar.htm","type":"SC 13G","id":"NTFILE2abCvf3kFEhEyVnf","market":"us","size":46721}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2023-02-24 13:00","pubTimestamp":1677214800,"title_zh":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17138255","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023010951-NLSPW","pdf_url":"","pub_time":1676350800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"NLSPW","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023010951/0001213900-23-010951-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023010951/ea173372-13ga1konofal_nls.htm","primary":true,"translateUrl":"","linkName":"ea173372-13ga1konofal_nls.htm","type":"SC 13G/A","id":"NTFILE4Tyq8Ywtzbxu9z84","market":"us","size":51400}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2023-02-14 13:00","pubTimestamp":1676350800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17138254","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023011541-NLSPW","pdf_url":"","pub_time":1676350800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"NLSPW","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023011541/0001213900-23-011541-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023011541/ea173613-13ga1magnet_nlsphar.htm","primary":true,"translateUrl":"","linkName":"ea173613-13ga1magnet_nlsphar.htm","type":"SC 13G/A","id":"NTFILE2YGMLRfV6ucrg9Aa","market":"us","size":72286}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2023-02-14 13:00","pubTimestamp":1676350800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17138256","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023010726-NLSPW","pdf_url":"","pub_time":1676264400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"NLSPW","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023010726/0001213900-23-010726-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023010726/ea173368-13ga1zwyer_nlspharm.htm","primary":true,"translateUrl":"","linkName":"ea173368-13ga1zwyer_nlspharm.htm","type":"SC 13G/A","id":"NTFILE46t3VWztwzTZ3gvk","market":"us","size":46969}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2023-02-13 13:00","pubTimestamp":1676264400,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17138262","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023003406-NLSPW","pdf_url":"","pub_time":1674018000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"NLSPW","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023003406/0001213900-23-003406-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390023003406/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE9ZVCzVP9xtpf1hvU","market":"us","size":5779}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2023-01-18 13:00","pubTimestamp":1674018000,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17138267","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465923000324-NLSPW","pdf_url":"","pub_time":1672722000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"NLSPW","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000110465923000324/0001104659-23-000324-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1463928/000110465923000324/tm231355d6_sc13ga.htm","primary":true,"translateUrl":"","linkName":"tm231355d6_sc13ga.htm","type":"SC 13G/A","id":"NTFILEJ9Ah4SYg7PaR3cY8","market":"us","size":145630},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1463928/000110465923000324/tm231355d6_ex99-1.htm","primary":false,"translateUrl":"","linkName":"tm231355d6_ex99-1.htm","type":"EX-99.1","id":"NTFILEeKhWkf1Rak6d3ePC","market":"us","size":14052}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2023-01-03 13:00","pubTimestamp":1672722000,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17138272","market":"us","labels":[],"media":"sec.gov","original_id":"AN92189522003221-NLSPW","pdf_url":"","pub_time":1671166800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"NLSPW","title":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000092189522003221/0000921895-22-003221-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"THE SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/918923/000092189522003221/sc13g07422nlsp_12162022.htm","primary":true,"translateUrl":"","linkName":"sc13g07422nlsp_12162022.htm","type":"SC 13G","id":"NTFILE2pcBBUNQT14r89rP","market":"us","size":279000},{"description":"JOINT FILING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/918923/000092189522003221/ex991to13g07422nlsp_12162022.htm","primary":false,"translateUrl":"","linkName":"ex991to13g07422nlsp_12162022.htm","type":"EX-99.1","id":"NTFILE8w6Ynk4VKZ8S1Psa","market":"us","size":8442}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2022-12-16 13:00","pubTimestamp":1671166800,"title_zh":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17138276","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390022079551-NLSPW","pdf_url":"","pub_time":1670907600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"NLSPW","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390022079551/0001213900-22-079551-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390022079551/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEF5mk5qYBa6Zu8kwd","market":"us","size":5816}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2022-12-13 13:00","pubTimestamp":1670907600,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744428","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021026511-NLSPW","pdf_url":null,"pub_time":1620921600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"NLSPW","title":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/0001213900-21-026511-index.htm","us_notice_code":"Form 20-F","us_title_en":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020_nlspharmaceutics.htm","primary":true,"translateUrl":null,"linkName":"f20f2020_nlspharmaceutics.htm","type":"20-F","id":"NTFILEGqfmMknxt5i4gnor","market":"us","size":1762972},{"description":"DESCRIPTION OF SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020ex2-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex2-1_nlspharma.htm","type":"EX-2.1","id":"NTFILEF6zH6KbYY4zRGW3z","market":"us","size":135478},{"description":"LICENSE AGREEMENT BY AND BETWEEN NLS PHARMACEUTICS LTD. AND NOVARTIS PHARMA AG,","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020ex4-6_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex4-6_nlspharma.htm","type":"EX-4.6","id":"NTFILE7omap9p1utNxsHrZ","market":"us","size":198323},{"description":"SUBSIDIARY","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020ex8-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex8-1_nlspharma.htm","type":"EX-8.1","id":"NTFILE2TV1rg1fDoshSnWF","market":"us","size":1241},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020ex12-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex12-1_nlspharma.htm","type":"EX-12.1","id":"NTFILEFjGqGcifkdEHyuNJ","market":"us","size":6925},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020ex12-2_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex12-2_nlspharma.htm","type":"EX-12.2","id":"NTFILE12jg34kUaCLvF4Nm","market":"us","size":6924},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020ex13-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex13-1_nlspharma.htm","type":"EX-13.1","id":"NTFILE2dSdRtMKzNWSVpYt","market":"us","size":2862},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020ex13-2_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex13-2_nlspharma.htm","type":"EX-13.2","id":"NTFILE8RUrnGj2DyfgQSJg","market":"us","size":2866},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/ex4-6_001.jpg","primary":false,"translateUrl":null,"linkName":"ex4-6_001.jpg","type":"GRAPHIC","id":"NTFILEG2ZkdADaAaAsYcK9","market":"us","size":230428},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/ex4-6_002.jpg","primary":false,"translateUrl":null,"linkName":"ex4-6_002.jpg","type":"GRAPHIC","id":"NTFILE4HK9GNi1mQ7M4rJJ","market":"us","size":96137},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/ex4-6_003.jpg","primary":false,"translateUrl":null,"linkName":"ex4-6_003.jpg","type":"GRAPHIC","id":"NTFILEFX84nZqVfo4eggYE","market":"us","size":97435},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/ex4-6_004.jpg","primary":false,"translateUrl":null,"linkName":"ex4-6_004.jpg","type":"GRAPHIC","id":"NTFILEEPaCKk3JZDEymJWD","market":"us","size":13491},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE3pJhcRx6UVhQbU4Z","market":"us","size":92638},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_002.jpg","primary":false,"translateUrl":null,"linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE9jCcXMfamx5YSXeQ","market":"us","size":56905},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_003.jpg","primary":false,"translateUrl":null,"linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILEFti1U5bxiyVboeAV","market":"us","size":85480},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_004.jpg","primary":false,"translateUrl":null,"linkName":"image_004.jpg","type":"GRAPHIC","id":"NTFILE93vEmNa9mXVZKDpo","market":"us","size":82749},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_005.jpg","primary":false,"translateUrl":null,"linkName":"image_005.jpg","type":"GRAPHIC","id":"NTFILE8NrS87sVcxPaqMRP","market":"us","size":35702},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_006.jpg","primary":false,"translateUrl":null,"linkName":"image_006.jpg","type":"GRAPHIC","id":"NTFILE8DzURdSbDuDrAezN","market":"us","size":43657},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_007.jpg","primary":false,"translateUrl":null,"linkName":"image_007.jpg","type":"GRAPHIC","id":"NTFILEAu7Mjo8zwuhJpo4L","market":"us","size":25128},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_008.jpg","primary":false,"translateUrl":null,"linkName":"image_008.jpg","type":"GRAPHIC","id":"NTFILECWm7jrnVYnsJeghY","market":"us","size":55758},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_009.jpg","primary":false,"translateUrl":null,"linkName":"image_009.jpg","type":"GRAPHIC","id":"NTFILEkdkjmiM2S58UmYxh","market":"us","size":36948},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_010.jpg","primary":false,"translateUrl":null,"linkName":"image_010.jpg","type":"GRAPHIC","id":"NTFILE7CGpfaibSgH1Hgn8","market":"us","size":41627},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_011.jpg","primary":false,"translateUrl":null,"linkName":"image_011.jpg","type":"GRAPHIC","id":"NTFILEHzCUtfU4zn3i5D2q","market":"us","size":130296},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/image_012.jpg","primary":false,"translateUrl":null,"linkName":"image_012.jpg","type":"GRAPHIC","id":"NTFILEGTjLCaBQqaZkpXyk","market":"us","size":63289}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"年度報告","pubTime":"2021-05-14 00:00","pubTimestamp":1620921600,"title_zh":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744349","market":"us","labels":[],"media":"sec.gov","original_id":"AN138713121003638-NLSPW","pdf_url":null,"pub_time":1615910400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"NLSPW","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000138713121003638/0001387131-21-003638-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT TO FORM SC 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1131362/000138713121003638/nlsp-sc13ga_031221.htm","primary":true,"translateUrl":null,"linkName":"nlsp-sc13ga_031221.htm","type":"SC 13G/A","id":"NTFILEHRQwMiTnoyPMKfKD","market":"us","size":98348}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-03-17 00:00","pubTimestamp":1615910400,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744338","market":"us","labels":[],"media":"sec.gov","original_id":"AN138713121001754-NLSPW","pdf_url":null,"pub_time":1612368000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"NLSPW","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000138713121001754/0001387131-21-001754-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1131362/000138713121001754/nlsp-sc13g_012921.htm","primary":true,"translateUrl":null,"linkName":"nlsp-sc13g_012921.htm","type":"SC 13G","id":"NTFILE4hNT2vxU8JHBejTd","market":"us","size":57553}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-04 00:00","pubTimestamp":1612368000,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744343","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021004018-NLSPW","pdf_url":null,"pub_time":1611504000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"NLSPW","title":"CORRESP [Cover] - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021004018/0001213900-21-004018-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021004018/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILE279mmk31PtX6yd8o","market":"us","size":5564}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2021-01-25 00:00","pubTimestamp":1611504000,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744336","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021004020-NLSPW","pdf_url":null,"pub_time":1611504000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"NLSPW","title":"CORRESP [Cover] - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021004020/0001213900-21-004020-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021004020/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILE2962Etn4kBMsz4ef","market":"us","size":7859}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2021-01-25 00:00","pubTimestamp":1611504000,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744340","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021002942-NLSPW","pdf_url":null,"pub_time":1611072000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"F-1/A [Amend] - Registration statement for certain foreign private issuers","symbol":"NLSPW","title":"F-1/A [Amend] - Registration statement for certain foreign private issuers","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/0001213900-21-002942-index.htm","us_notice_code":"Form F-1/A","us_title_en":"F-1/A [Amend] - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 5 TO FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431-f1a5_nlspharma.htm","primary":true,"translateUrl":null,"linkName":"ea133431-f1a5_nlspharma.htm","type":"F-1/A","id":"NTFILEEzi6r3nUxYp8YuCo","market":"us","size":2082569},{"description":"FORM OF UNDERWRITING AGREEMENT BY AND AMONG NLS PHARMACEUTICS LTD. AND THE UNDER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex1-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex1-1_nlspharma.htm","type":"EX-1.1","id":"NTFILEGHffj2Uf6MBNGqDP","market":"us","size":437305},{"description":"AMENDMENT NUMBER 4 TO CONVERTIBLE LOAN AGREEMENT DATED FEBRUARY 21, 2020 BETWEEN","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex10-29_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex10-29_nlspharma.htm","type":"EX-10.29","id":"NTFILEBi8NqBSL91bxK7EX","market":"us","size":17496},{"description":"AMENDMENT NUMBER 2 TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND M","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex10-30_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex10-30_nlspharma.htm","type":"EX-10.30","id":"NTFILEBuawuwGs7s9gP9j5","market":"us","size":29512},{"description":"AMENDMENT NUMBER 3 TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND M","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex10-31_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex10-31_nlspharma.htm","type":"EX-10.31","id":"NTFILEGwPhgfwCK5oL3K64","market":"us","size":21337},{"description":"FORM OF ADDENDUM NUMBER 4 TO PROMISSORY NOTE DATED JANUARY 2019 BETWEEN CERTAIN","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex10-32_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex10-32_nlspharma.htm","type":"EX-10.32","id":"NTFILEBSzA4hU4VUVSVRvz","market":"us","size":14323},{"description":"ADDENDUM NUMBER 4 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS PHARMA AG","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex10-33_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex10-33_nlspharma.htm","type":"EX-10.33","id":"NTFILE6n2SerrLcxWPkTaU","market":"us","size":21929},{"description":"ADDENDUM NUMBER 4 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS-1 PHARMA","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex10-34_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex10-34_nlspharma.htm","type":"EX-10.34","id":"NTFILEAPYVcjPbycHzzFke","market":"us","size":54351},{"description":"ADDENDUM NUMBER 4 TO CONVERTIBLE PROMISSORY NOTE DATED JANUARY 18, 2019 BETWEEN","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex10-35_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex10-35_nlspharma.htm","type":"EX-10.35","id":"NTFILE9n9c8REwKLPqF8H5","market":"us","size":18127},{"description":"CONSENT OF MARCUM LLP","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex23-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex23-1_nlspharma.htm","type":"EX-23.1","id":"NTFILE7Li75J11L3Ro5WaJ","market":"us","size":3160},{"description":"REGISTRANT'S REPRESENTATION PURSUANT TO REQUIREMENTS OF FORM 20-F, ITEM 8.A.4","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431ex99-3_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea133431ex99-3_nlspharma.htm","type":"EX-99.3","id":"NTFILE3Mv7eqs91vTtzRTt","market":"us","size":10752},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE8mzwFHLuNDcRPz82","market":"us","size":14073},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_004a.jpg","primary":false,"translateUrl":null,"linkName":"image_004a.jpg","type":"GRAPHIC","id":"NTFILE9sbqUgays2Y8M236","market":"us","size":30789},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_005.jpg","primary":false,"translateUrl":null,"linkName":"image_005.jpg","type":"GRAPHIC","id":"NTFILEARbnmfLb1pQ12vNs","market":"us","size":34402},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_006.jpg","primary":false,"translateUrl":null,"linkName":"image_006.jpg","type":"GRAPHIC","id":"NTFILE84C3wjLjzxbUqeUn","market":"us","size":14916},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_007.jpg","primary":false,"translateUrl":null,"linkName":"image_007.jpg","type":"GRAPHIC","id":"NTFILEFRELDWyynNg8WT17","market":"us","size":17745},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_008.jpg","primary":false,"translateUrl":null,"linkName":"image_008.jpg","type":"GRAPHIC","id":"NTFILEsgLeM9JzVkW2XmDp","market":"us","size":11253},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_009.jpg","primary":false,"translateUrl":null,"linkName":"image_009.jpg","type":"GRAPHIC","id":"NTFILE2yd5LNs499UXvBg1","market":"us","size":22650},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_010.jpg","primary":false,"translateUrl":null,"linkName":"image_010.jpg","type":"GRAPHIC","id":"NTFILE3CW4jDLNNRknte4j","market":"us","size":15414},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_011.jpg","primary":false,"translateUrl":null,"linkName":"image_011.jpg","type":"GRAPHIC","id":"NTFILEB1qahmkTsVFLbwVw","market":"us","size":18536},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_012.jpg","primary":false,"translateUrl":null,"linkName":"image_012.jpg","type":"GRAPHIC","id":"NTFILE57Ng5f6yVhmJD45T","market":"us","size":23274},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_013.jpg","primary":false,"translateUrl":null,"linkName":"image_013.jpg","type":"GRAPHIC","id":"NTFILEFLSfVsC3hAsqa1ZD","market":"us","size":46910},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_014.jpg","primary":false,"translateUrl":null,"linkName":"image_014.jpg","type":"GRAPHIC","id":"NTFILEHCqrzNFBeUHeUvf5","market":"us","size":13369},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_015.jpg","primary":false,"translateUrl":null,"linkName":"image_015.jpg","type":"GRAPHIC","id":"NTFILE958TH3Tou1WUSrJR","market":"us","size":46220},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/image_016.jpg","primary":false,"translateUrl":null,"linkName":"image_016.jpg","type":"GRAPHIC","id":"NTFILEA2jgMo278S1TQkdJ","market":"us","size":95983}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2021-01-20 00:00","pubTimestamp":1611072000,"title_zh":"F-1/A [Amend] - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744329","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020038102-NLSPW","pdf_url":null,"pub_time":1605715200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"NLSPW","title":"CORRESP [Cover] - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020038102/0001213900-20-038102-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020038102/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILECA8hKX7BrA4MRFfN","market":"us","size":11315}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2020-11-19 00:00","pubTimestamp":1605715200,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744331","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020037777-NLSPW","pdf_url":null,"pub_time":1605542400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"F-1/A [Amend] - Registration statement for certain foreign private issuers","symbol":"NLSPW","title":"F-1/A [Amend] - Registration statement for certain foreign private issuers","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/0001213900-20-037777-index.htm","us_notice_code":"Form F-1/A","us_title_en":"F-1/A [Amend] - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 4 TO FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/ea130034-f1a4_nlspharma.htm","primary":true,"translateUrl":null,"linkName":"ea130034-f1a4_nlspharma.htm","type":"F-1/A","id":"NTFILE7ig4BG1eJtmpwxyM","market":"us","size":2092837},{"description":"CONSENT OF MARCUM LLP.","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/ea130034ex23-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea130034ex23-1_nlspharma.htm","type":"EX-23.1","id":"NTFILEuo7121Kj6pqRsrEW","market":"us","size":2240},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILECJZ5sSLFKwqw4k7U","market":"us","size":14073},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_003.jpg","primary":false,"translateUrl":null,"linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILE64ATUdkzKx9yymfp","market":"us","size":11362},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_004.jpg","primary":false,"translateUrl":null,"linkName":"image_004.jpg","type":"GRAPHIC","id":"NTFILE9MRJjKCpj6t2vwn7","market":"us","size":10855},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_004a.jpg","primary":false,"translateUrl":null,"linkName":"image_004a.jpg","type":"GRAPHIC","id":"NTFILE6VhcntyQjJ4vXv7X","market":"us","size":30789},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_005.jpg","primary":false,"translateUrl":null,"linkName":"image_005.jpg","type":"GRAPHIC","id":"NTFILEAxExCokahqmHy9kv","market":"us","size":34402},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_006.jpg","primary":false,"translateUrl":null,"linkName":"image_006.jpg","type":"GRAPHIC","id":"NTFILEHTXAec7QirRCWU7v","market":"us","size":14916},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_007.jpg","primary":false,"translateUrl":null,"linkName":"image_007.jpg","type":"GRAPHIC","id":"NTFILE35jeyC7NwWPNaGG6","market":"us","size":17745},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_008.jpg","primary":false,"translateUrl":null,"linkName":"image_008.jpg","type":"GRAPHIC","id":"NTFILEEsLwcFN2t9GN1nJL","market":"us","size":11253},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_009.jpg","primary":false,"translateUrl":null,"linkName":"image_009.jpg","type":"GRAPHIC","id":"NTFILEFXpzfRNUKN4Syjzi","market":"us","size":22650},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_010.jpg","primary":false,"translateUrl":null,"linkName":"image_010.jpg","type":"GRAPHIC","id":"NTFILEDLLiYD11ZnEZpA7f","market":"us","size":15414},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_011.jpg","primary":false,"translateUrl":null,"linkName":"image_011.jpg","type":"GRAPHIC","id":"NTFILEGXt5LvzHdNvyVQf3","market":"us","size":18536},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_012.jpg","primary":false,"translateUrl":null,"linkName":"image_012.jpg","type":"GRAPHIC","id":"NTFILE775Mv7RJem4kwmVy","market":"us","size":23274},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/image_013.jpg","primary":false,"translateUrl":null,"linkName":"image_013.jpg","type":"GRAPHIC","id":"NTFILE4Yo5jKAcpsCpUCji","market":"us","size":46910},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/img_0013.jpg","primary":false,"translateUrl":null,"linkName":"img_0013.jpg","type":"GRAPHIC","id":"NTFILEvwPEnkJyLoL1XMw8","market":"us","size":13369}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2020-11-17 00:00","pubTimestamp":1605542400,"title_zh":"F-1/A [Amend] - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744339","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020036675-NLSPW","pdf_url":null,"pub_time":1605196800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"F-1/A [Amend] - Registration statement for certain foreign private issuers","symbol":"NLSPW","title":"F-1/A [Amend] - Registration statement for certain foreign private issuers","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/0001213900-20-036675-index.htm","us_notice_code":"Form F-1/A","us_title_en":"F-1/A [Amend] - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 3 TO FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ea129645-f1a3_nlspharma.htm","primary":true,"translateUrl":null,"linkName":"ea129645-f1a3_nlspharma.htm","type":"F-1/A","id":"NTFILE8s4G1wDa1udEfkX9","market":"us","size":83661},{"description":"FORM OF UNDERWRITING AGREEMENT BY AND AMONG NLS PHARMACEUTICS LTD. AND THE UNDER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ea129645ex1-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea129645ex1-1_nlspharma.htm","type":"EX-1.1","id":"NTFILEVEwd62TA5p2e1Xvp","market":"us","size":439127},{"description":"FORM OF WARRANT AGENT AGREEMENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ea129645ex4-2_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea129645ex4-2_nlspharma.htm","type":"EX-4.2","id":"NTFILE2iRkyDkupLsAQ6ke","market":"us","size":138580},{"description":"FORM OF WARRANT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ea129645ex4-3_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea129645ex4-3_nlspharma.htm","type":"EX-4.3","id":"NTFILECNzj2Wmiu1sVgSny","market":"us","size":100698},{"description":"OPINION OF WENGER & VIELI AG, SWISS COUNSEL TO NLS PHARMACEUTICS LTD","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ea129645ex5-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea129645ex5-1_nlspharma.htm","type":"EX-5.1","id":"NTFILE5QnEqrJzobh5n8vo","market":"us","size":32467},{"description":"OPINION OF SULLIVAN & WORCESTER LLP, U.S. COUNSEL TO NLS PHARMACEUTICS LTD","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ea129645ex5-2_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea129645ex5-2_nlspharma.htm","type":"EX-5.2","id":"NTFILEHnMNgtyopn4nkmEn","market":"us","size":13545},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ex5-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEBDCc3dCizAGRD1q7","market":"us","size":12434},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ex5-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE8vwrkfVRwHikDNec","market":"us","size":24666},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ex5-2_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILEBUpT8rdsFnCa4EMj","market":"us","size":18197},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ex5-2_002.jpg","primary":false,"translateUrl":null,"linkName":"ex5-2_002.jpg","type":"GRAPHIC","id":"NTFILEFauAbr1gyWcoLWuQ","market":"us","size":6999}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2020-11-13 00:00","pubTimestamp":1605196800,"title_zh":"F-1/A [Amend] - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12744358","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020031906-NLSPW","pdf_url":null,"pub_time":1603036800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"F-1/A [Amend] - Registration statement for certain foreign private issuers","symbol":"NLSPW","title":"F-1/A [Amend] - Registration statement for certain foreign private issuers","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/0001213900-20-031906-index.htm","us_notice_code":"Form F-1/A","us_title_en":"F-1/A [Amend] - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO.2 TO REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281-f1a2_nlspharma.htm","primary":true,"translateUrl":null,"linkName":"ea128281-f1a2_nlspharma.htm","type":"F-1/A","id":"NTFILE4HAxw6F8nQFZ8kba","market":"us","size":2085302},{"description":"FORM OF AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF NLS PHARMACEUTICS LTD.","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex3-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex3-1_nlspharma.htm","type":"EX-3.1","id":"NTFILE8m2gCtTDY2KqvoJq","market":"us","size":216781},{"description":"AMENDMENT NUMBER 2 TO CONVERTIBLE LOAN AGREEMENT DATED FEBRUARY 21, 2020 BETWEEN","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-20_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-20_nlspharma.htm","type":"EX-10.20","id":"NTFILE889ZYTPqVSw7PNgv","market":"us","size":42606},{"description":"AMENDMENT NUMBER 3 TO CONVERTIBLE LOAN AGREEMENT DATED FEBRUARY 21, 2020 BETWEEN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-21_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-21_nlspharma.htm","type":"EX-10.21","id":"NTFILEGmJcBAqEVd6R97Vk","market":"us","size":26829},{"description":"BRIDGELOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND MAGNETIC ROCK INVESTMENT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-22_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-22_nlspharma.htm","type":"EX-10.22","id":"NTFILEEbNzjnMicWjuA6jh","market":"us","size":143082},{"description":"AMENDMENT TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND MAGNETIC R","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-23_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-23_nlspharma.htm","type":"EX-10.23","id":"NTFILE9Rw8AMmpKvczoJRD","market":"us","size":28526},{"description":"FORM OF AMENDMENT TO CONVERTIBLE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. A","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-24_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-24_nlspharma.htm","type":"EX-10.24","id":"NTFILEHtb7HPPhPjvy4Uqd","market":"us","size":15485},{"description":"FORM OF ADDENDUM NUMBER 3 TO PROMISSORY NOTE DATED JANUARY 2019 BETWEEN CERTAIN","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-25_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-25_nlspharma.htm","type":"EX-10.25","id":"NTFILEE2iE94uLd1UFBY6q","market":"us","size":10937},{"description":"ADDENDUM NUMBER 3 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS PHARMA AG","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-26_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-26_nlspharma.htm","type":"EX-10.26","id":"NTFILE4yZLChA3KCPNyCxr","market":"us","size":41151},{"description":"ADDENDUM NUMBER 3 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS-1 PHARMA","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-27_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-27_nlspharma.htm","type":"EX-10.27","id":"NTFILE36YVeGDVVq7NWe2B","market":"us","size":68326},{"description":"ADDENDUM NUMBER 2 TO CONVERTIBLE PROMISSORY NOTE DATED JANUARY 18, 2019 BETWEEN","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex10-28_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex10-28_nlspharma.htm","type":"EX-10.28","id":"NTFILEDeCHzpKpEcBu9DCK","market":"us","size":18930},{"description":"CONSENT OF MARCUM LLP","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex23-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex23-1_nlspharma.htm","type":"EX-23.1","id":"NTFILE4QWHJ2gXs6nm4QUn","market":"us","size":2345},{"description":"CONSENT OF STIG LOKKE PEDERSEN","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex99-1_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex99-1_nlspharma.htm","type":"EX-99.1","id":"NTFILEGGWvVJNNg6fpTYxt","market":"us","size":2685},{"description":"CONSENT OF MYOUNG-OK KWON","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281ex99-2_nlspharma.htm","primary":false,"translateUrl":null,"linkName":"ea128281ex99-2_nlspharma.htm","type":"EX-99.2","id":"NTFILEGKwCekn5KNx6xvQo","market":"us","size":2733},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILECetvQDixCc22pqsG","market":"us","size":14131},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_003.jpg","primary":false,"translateUrl":null,"linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILE2cZWBG97dukFkjtP","market":"us","size":11343},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_004.jpg","primary":false,"translateUrl":null,"linkName":"image_004.jpg","type":"GRAPHIC","id":"NTFILEESHjBQkMFWyxLGuw","market":"us","size":10922},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_004a.jpg","primary":false,"translateUrl":null,"linkName":"image_004a.jpg","type":"GRAPHIC","id":"NTFILE7UMrmTmdJCbPx4wQ","market":"us","size":30867},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_005.jpg","primary":false,"translateUrl":null,"linkName":"image_005.jpg","type":"GRAPHIC","id":"NTFILE9CASdcZ4n9pGVR1z","market":"us","size":34663},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_006.jpg","primary":false,"translateUrl":null,"linkName":"image_006.jpg","type":"GRAPHIC","id":"NTFILEENaRwXXvGYV6X4WN","market":"us","size":15000},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_007.jpg","primary":false,"translateUrl":null,"linkName":"image_007.jpg","type":"GRAPHIC","id":"NTFILEBcvmvbdZX9tvjkvT","market":"us","size":17818},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_008.jpg","primary":false,"translateUrl":null,"linkName":"image_008.jpg","type":"GRAPHIC","id":"NTFILE545m1VVLCTgSLaG4","market":"us","size":11186},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_009.jpg","primary":false,"translateUrl":null,"linkName":"image_009.jpg","type":"GRAPHIC","id":"NTFILE78vmUwcdEmtxSFgu","market":"us","size":22705},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_010.jpg","primary":false,"translateUrl":null,"linkName":"image_010.jpg","type":"GRAPHIC","id":"NTFILEBnSpKjUv2cMBurKn","market":"us","size":15542},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_011.jpg","primary":false,"translateUrl":null,"linkName":"image_011.jpg","type":"GRAPHIC","id":"NTFILEAKkm5rxuuXJgoZLW","market":"us","size":18579},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_012.jpg","primary":false,"translateUrl":null,"linkName":"image_012.jpg","type":"GRAPHIC","id":"NTFILEp6FAQcG77f5BqoD5","market":"us","size":23384},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/image_013.jpg","primary":false,"translateUrl":null,"linkName":"image_013.jpg","type":"GRAPHIC","id":"NTFILEE4p8oCUzCvzf439c","market":"us","size":47066},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/img_0013.jpg","primary":false,"translateUrl":null,"linkName":"img_0013.jpg","type":"GRAPHIC","id":"NTFILEHZkb4YceLFv9BCw8","market":"us","size":47064},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ex10-24_001.jpg","primary":false,"translateUrl":null,"linkName":"ex10-24_001.jpg","type":"GRAPHIC","id":"NTFILE2mqYPNZfu1tWvcuA","market":"us","size":10578}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2020-10-19 00:00","pubTimestamp":1603036800,"title_zh":"F-1/A [Amend] - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}